BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/20/2015 5:01:00 PM | Browse: 1379 | Download: 2112
 |
Received |
|
2014-09-24 18:23 |
|
Peer-Review Started |
|
2014-09-25 14:44 |
|
To Make the First Decision |
|
2014-10-29 14:22 |
|
Return for Revision |
|
2014-11-13 10:01 |
|
Revised |
|
2014-11-25 15:05 |
|
Second Decision |
|
2014-12-04 14:43 |
|
Accepted by Journal Editor-in-Chief |
|
2014-12-04 20:11 |
|
Accepted by Company Editor-in-Chief |
|
2014-12-16 10:05 |
|
Articles in Press |
|
2014-12-16 10:38 |
 |
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2014-12-30 09:08 |
|
Typeset the Manuscript |
|
2015-05-12 17:20 |
|
Publish the Manuscript Online |
|
2015-05-20 17:01 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Meta-Analysis |
| Article Title |
Infliximab is superior to the other biological agents for the treatment of active ulcerative colitis: A meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Wei-Qun Mei, Hui-Zhen Hu, Ying Liu, Zhi-Chen Li and Wei-Guo Wang |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dr. Wei-Guo Wang, Department of Gastroenterology, No. 117 Hospital of PLA, 14 Lingyin Road, Hangzhou 310021, Zhejiang Province, China. wangweiguo117@126.com |
| Key Words |
Biological agents; Efficacy; Meta-analysis; Safety; Ulcerative colitis |
| Core Tip |
Currently the option of biological agents in ulcerative colitis (UC) therapy was still controversial. We performed this meta-analysis to compare the efficacy and safety of biological agents for the treatment of active UC, and finally found all biological agents were superior to placebo for UC treatment in both induction and maintenance phases with a similar safety, and infliximab had a better clinical effect than the other biological agents. |
| Publish Date |
2015-05-20 17:01 |
| Citation |
Mei WQ, Hu HZ, Liu Y, Li ZC, Wang WG. Infliximab is superior to other biological agents for treatment of active ulcerative colitis: A meta-analysis. World J Gastroenterol 2015; 21(19): 6044-6051 |
| URL |
http://www.wjgnet.com/1007-9327/full/v21/i19/6044.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v21.i19.6044 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
